Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia after the First Epidemic Wave in 2020: A National Survey
Author(s):
Kaitlyn M. Vette, Dorothy A. Machalek, Heather F. Gidding, Suellen Nicholson, Matthew V.N. O'Sullivan, John B. Carlin, Marnie Downes, Lucy Armstrong, Frank H. Beard, Dominic E. Dwyer, Robert Gibb, Iain B. Gosbell, Alexandra J. Hendry, Geoff Higgins, Rena Hirani, Linda Hueston, David O. Irving, Helen E. Quinn, Hannah Shilling, David Smith, John M. Kaldor, Kristine Macartney
Details:
Open Forum Infectious Diseases, Volume 9, Issue 3, 2022-03-01, Article number ofac002
Article Link: Click here
Affiliations:
- The University of Sydney
- University of Technology Sydney
- Griffith University
- Western Sydney University
- Royal Melbourne Hospital
- Murdoch Children's Research Institute
- Department of Paediatrics
- The Kirby Institute
- Royal Women's Hospital, Carlton
- Kolling Institute of Medical Research
- The University of Sydney Northern Clinical School
- PathWest Laboratory Medicine WA
- National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Australia
- Australian Red Cross
- Pathology Queensland
- Institute of Clinical Pathology and Medical Research
- South Australia Pathology

